HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
QURE
uniQure N.V.
QURE lost money over the past year, so it has no meaningful PE right now.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
QURE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Strong |
QURE's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
QURE PE Valuation
QURE has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
QURE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect QURE's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
QURE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.52 | +$0.86 |
| Q2 2026 | -$4.02 | -$0.11 |
| Q1 2026 | -$3.49 | +$0.89 |
| Q4 2025 | -$3.46 | +$1.46 |
| Q3 2025 | -$4.38 | +$0.57 |
| Q2 2025 | -$3.91 | +$2.01 |
| Q1 2025 | -$4.38 | +$1.82 |
| Q4 2024 | -$4.92 | +$1.55 |
QURE has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over QURE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over QURE on profitability, with a higher operating margin.
QURE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.2M | +40% |
| Q2 2026 | $5.8M | +11% |
| Q1 2026 | $3.6M | +127% |
| Q4 2025 | $5.6M | +6.6% |
| Q3 2025 | $3.7M | +62% |
| Q2 2025 | $5.3M | -53% |
| Q1 2025 | $1.6M | -82% |
| Q4 2024 | $5.2M | -22% |
QURE's revenue is recovering but still below its 2021 peak: $5M last quarter, up 40% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1020% | +359 points |
| Q2 2026 | -894% | -60 points |
| Q1 2026 | -1284% | +1226 points |
| Q4 2025 | -918% | -40 points |
| Q3 2025 | -1379% | +380 points |
| Q2 2025 | -834% | -438 points |
| Q1 2025 | -2510% | -1871 points |
| Q4 2024 | -878% | +45 points |
QURE's operating margin was −1020% last quarter, up 359 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over QURE on cash generation, producing positive trailing cash flow while its opponent burns cash.
QURE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$47.8M | -$31.5M |
| Q2 2026 | -$29M | +$11.1M |
| Q1 2026 | -$38.4M | +$5.8M |
| Q4 2025 | -$77.7M | -$24.8M |
| Q3 2025 | -$16.3M | +$20.6M |
| Q2 2025 | -$40.2M | -$6.8M |
| Q1 2025 | -$44.2M | +$18.7M |
| Q4 2024 | -$52.9M | -$1.3M |
QURE has burned cash in almost every quarter: −$193M over the past year, against −$154M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over QURE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
QURE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.5% | +3.7M shares |
| 1 year | +19% | +11.4M shares |
| 3 years | +46% | +22.1M shares |
| 5 years | +51% | +23.7M shares |
| Available history | +75% | +29.9M shares |
QURE has 70M diluted shares, up 19% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
QURE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | -1.4x | Net Cash |
| Q4 2021 | -1.4x | Net Cash |
QURE has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
QURE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.4 | Neutral |
| Stochastic | 10.8 | Oversold |
QURE's weekly RSI is 41 (neutral) and its Stochastic is 11 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
QURE PE vs Healthcare Sector
| Metric | QURE | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
QURE has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
QURE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.0 | 1.3% below |
| 20 week MA | $36.6 | 33% below |
| 50 week MA | $28.6 | 14% below |
| 100 week MA | $24.8 | 0.6% below |
| 200 week MA | $17.3 | 43% above |
QURE has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
QURE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $72.5 | $38.1 | -47% |
| 2021 | $38.1 | $22.3 | -42% |
| 2022 | $22.3 | $23.3 | +4.7% |
| 2023 | $23.3 | $6.77 | -71% |
| 2024 | $6.77 | $17.5 | +158% |
| 2025 | $17.5 | $24.8 | +42% |
| 2026 YTD | $24.8 | $24.6 | -0.7% |
QURE has the edge over HIMS on returns for 2026, with the stronger performance.